Moteur de recherche d’entreprises européennes

Financement de l’UE (4 955 877 €) : Vers des ressources et des services durables pour les souris qui font progresser la recherche sur la santé et les maladies humaines Hor19/12/2016 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Vers des ressources et des services durables pour les souris qui font progresser la recherche sur la santé et les maladies humaines

The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse models for basic research of human health and disease, and to translate this knowledge into therapeutic approaches for the benefit of the European society. The expanded INFRAFRONTIER2020 network, coordinated by the INFRAFRONTIER GmbH, includes 3 SMEs and is strategically responding to the INFRADEV3 call with aligned objectives to advance the long-term sustainability which are 1) development of business models and a stable legal framework; 2) raise awareness of the INFRAFRONTIER RI; 3) provide bespoke services aligned with user demands; 4) promote best practices in mouse phenogenomics; 5) enhance robustness of the INFRAFRONTIER IT infrastructure and use of the EMMA strain resource; and 6) improve business processes. Towards achieving these objectives key INFRAFRONTIER2020 project deliverables are: • INFRAFRONTIER Business Plan2.0, and business models for all services • Stable legal framework built on the INFRAFRONTIER legal entity • INFRAFRONTIER annual stakeholder conferences • Customised mouse model and secondary phenotyping pilot services • INFRAFRONTIER advanced training schools in mouse phenogenomics • Reengineered EMMA Database2.0 system • Annotated mouse models of human diseases • Quality management system for the legal entity INFRAFRONTIER2020 will 1) enhance the sustainable operation of the INFRAFRONTIER RI; 2) continue to structure the ERA, 3) foster innovation, and 4) address major societal challenges in human health by customised service pilots supporting research into common and rare diseases. A sustainable INFRAFRONTIER RI will ensure the quality of deposited mice and support the reproducibility of biological results. Outreach efforts will raise awareness of resources and services and facilitate sustainable engagement with industry and global consortia such as the International Mouse Phenotyping Consortium


Academisch Ziekenhuis Groningen 20 800 €
Agencia Estatal Consejo Superior de Investigaciones Cientificas 72 625 €
Ayoxxa Biosystems GmbH 20 800 €
Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis 91 125 €
Centre Europeen de Recherche en Biologie et en Medecine 306 900 €
Centre National de la Recherche Scientifique CNRS 69 774 €
Consiglio Nazionale Delle Ricerche 384 000 €
Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk 215 600 €
European Molecular Biology Laboratory 212 800 €
Fundacao Calouste Gulbenkian 120 540 €
Genome Research Ltd. LBG 69 875 €
Helmholtz-Zentrum FUR Infektionsforschung GmbH 12 800,00 €
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit UND Umwelt GmbH 477 873 €
Infrafrontier GmbH 1 713 235 €
Institut National de la Sante et de la Recherche Medicale 220 925 €
Institut Pasteur 42 600 €
Karolinska Institutet 77 321 €
Kobenhavns Universitet 22 400 €
Medizinische Hochschule Hannover 17 600,00 €
Oulun Yliopisto 140 100 €
Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis 114 750 €
TEL Aviv University 12 800,00 €
The University of Sheffield 40 800 €
Toronto Centre for Phenogenomics Inc. 0,00 €
TSE Systems GmbH 25 600 €
United Kingdom Research and Innovation 227 906 €
Universitat Autonoma de Barcelona 12 800,00 €
Ustav Molekularni Genetiky AV CR V.V.I. 195 528 €
Veterinaermedizinische Universitaet Wien 16 000,00 €

https://cordis.europa.eu/project/id/730879

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.